Column Capital Advisors, LLC 10x Genomics, Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 2,638 shares of TXG stock, worth $58,247. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,638
Previous 2,638
-0.0%
Holding current value
$58,247
Previous $147,000
26.53%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TXG
# of Institutions
284Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$225 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$206 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$141 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$136 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$136 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $2.1B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...